Efficacy and Safety of ACH24 in the Treatment of Vitiligo

Summary

This is a multicenter clinical trial, phase III, randomized, placebo-controlled, parallel group, enroll 94 patients, to assess the efficacy of ACH24 in the repigmentation of achromatic areas in patients with vitiligo.

Timeline

Start

2012-01

Primary completion

2013-12

Completion

—

Outcome

Outcome not reported

Stopped: “The Brazilian regulatory agency - ANVISA has requested the cancellation of the phase 3 study for conducting a phase 1 study first.”

Drugs

Indications